| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10308911 | Seizure | 2012 | 5 Pages |
Abstract
Our preliminary study suggests that obese patients with epilepsy treated with VPA are at higher risk of MetS than individuals who are “simply obese” but otherwise well. Therefore, the HOMA index should be monitored in obese patients who receive VPA therapy, rather than monitoring body weight alone.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Jiajia Fang, Sihan Chen, Nanwei Tong, Lan Chen, Dongmei An, Jie Mu, Dong Zhou,